Related Experiment Video

Updated: Jun 26, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Medical and Catheter-Based Therapies for Managing Stable Coronary Disease: Lessons From the COURAGE Trial

Dean J Kereiakes1

  • 1Dean J. Kereiakes, MD The Christ Hospital Heart and Vascular Center, The Lindner Center, 2123 Auburn Avenue, Suite 424, Cincinnati, OH 45219, USA. lindner@fuse.net.

Current Treatment Options in Cardiovascular Medicine
|January 15, 2009
PubMed

Insights

Choosing between medical therapy and percutaneous coronary intervention for stable coronary atherosclerosis requires personalized assessment. Objective evidence of ischemia guides treatment, with intervention improving outcomes when added to optimal medical therapy.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nuclear Cardiology

Background:

  • Stable coronary atherosclerosis necessitates individualized treatment strategies.
  • Medical and catheter-based therapies offer complementary approaches.
  • Patient-specific factors significantly influence treatment selection.

Purpose of the Study:

  • To outline the decision-making process for selecting optimal therapies in stable coronary atherosclerosis.
  • To highlight the prognostic value of objective ischemia assessment.
  • To compare the efficacy of percutaneous coronary intervention plus medical therapy versus medical therapy alone.

Main Methods:

  • Coronary angiography to define coronary anatomy.
  • Nuclear myocardial scintigraphy to objectively assess myocardial ischemia.
  • Evaluation of patient lifestyle, functional capacity, and symptom limitation.

Main Results:

  • Objective evidence of myocardial ischemia quantitatively correlates with adverse outcomes.
  • Percutaneous coronary intervention (PCI) combined with optimal medical therapy (OMT) is more effective than OMT alone in reducing ischemia.
  • Coronary anatomy assessment is crucial for optimal treatment strategy selection.

Conclusions:

  • Treatment decisions for stable coronary atherosclerosis must integrate coronary anatomy, ischemia severity, and patient-specific factors.
  • Nuclear myocardial scintigraphy provides critical prognostic information.
  • PCI offers significant benefits over OMT alone for selected patients with evidence of ischemia.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...